Drugs / Psirelax
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01000714 | — | psoriasis | Etwal Ltd. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Psirelax | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01000714 ↗ |
| Route | Topical | “Psirelax is a novel topical medication directed for the treatment of patients with psoriasis.” NCT01000714 ↗ |